Court Lifts Stay of ThermoLife Patent Infringement Cases Against Hi-Tech Pharmaceuticals
6 September 2017 - - US-based dietary supplement developer and nitrate technology specialist ThermoLife International, LLC has announced that the United States District Court for the Northern District of Georgia recently lifted its stay of ThermoLife's patent infringement suits against Hi-Tech Pharmaceuticals, Inc. and its owner, Jared Wheat, the company said. 
Thermolife has asserted infringement of multiple of these patents against Hi-Tech.
The Court's August 7, 2017 orders lifting the previously-entered stays follow ThermoLife's lengthy reexamination proceedings before the United States Patent and Trademark Office involving 10 ThermoLife nitrate technology-related patents, which concluded with the Patent Office issuing over 350 claims in the reexamined patents, including 181 new claims.
ThermoLife developed its creatine nitrate technology to offer consumers the health and performance benefits of nitrates while at the same time improving upon the physiological properties of creatine and other amino acids. These improvements include substantial enhancements in solubility, stability, and dissolution. 
Along with Hi-Tech and Jared Wheat, ThermoLife's lawsuits have named several retailers and distributors of Hi-Tech's products, including A1 Supplements, Muscle Foods USA, Supplement Central, and Supplement Warehouse.
ThermoLife patents ingredients and technology for use in dietary supplements, specializing in nitrate technology.
The company has a global patent portfolio of 27 patents spanning more than 25 countries, including more than 450 issued claims related to the use of nitrates in dietary supplements.